Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
17.92
-1.10 (-5.78%)
At close: May 15, 2026, 4:00 PM EDT
17.93
+0.01 (0.06%)
After-hours: May 15, 2026, 4:10 PM EDT
Lyell Immunopharma Employees
Lyell Immunopharma had 300 employees as of December 31, 2024. The number of employees increased by 76 or 33.93% compared to the previous year.
Employees
300
Change (1Y)
76
Growth (1Y)
33.93%
Revenue / Employee
$103
Profits / Employee
-$821,353
Market Cap
418.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 300 | 76 | 33.93% | 300 | 0 |
| Dec 31, 2023 | 224 | -50 | -18.25% | 224 | 0 |
| Dec 31, 2022 | 274 | 55 | 25.11% | 274 | 0 |
| Dec 31, 2021 | 219 | 29 | 15.26% | 219 | 0 |
| Mar 31, 2021 | 190 | - | - | 188 | 2 |
| Dec 31, 2020 | 190 | - | - | 188 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Replimune Group | 479 |
| ADC Therapeutics | 193 |
| Century Therapeutics | 78 |
| Lexeo Therapeutics | 59 |
| PureTech Health | 56 |
| Eupraxia Pharmaceuticals | 49 |
| vTv Therapeutics | 26 |
LYEL News
- 4 days ago - Lyell Immunopharma Announces Participation in May Investor Conferences - GlobeNewsWire
- 10 days ago - Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026 - GlobeNewsWire
- 15 days ago - Lyell Immunopharma initiated with an Outperform at Baird on ronde-cel potential - TheFly
- 16 days ago - Lyell Immunopharma initiated with an Outperform at Baird - TheFly
- 4 weeks ago - Lyell Immunopharma Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 5 weeks ago - Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks
- 5 weeks ago - Lyell Immunopharma initiated with a Buy at Needham - TheFly
- 5 weeks ago - Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire